FDA Investigator Emily B Camire

Emily B Camire has inspections in 2 countries as of 11 Jan 2024. Emily B Camire has collaborated with a combinined 1701 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
51
Last Inspection Date:
11 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
100007100
Country:
United States of America
Co-Investigator(s):
Abby Lmozeke Baker, Alanna Lmussawwir Bias, Albert F Peacock, PhD, Alexander M Kay, Angel K Sandhu, Anthony E Keller, RPh, Barbara A Rusin, Blondell W Johnson, Brandon K Lawson, Brent W Higgs, Bryce A May, Catherine V Quinlan, Celeta S Coves, Creighton T Tuzon, Crystal M Young Lewis, Cynthia Jim, CSO, Daniel Pst Laurent, Deborah S Hammond, Dennis R Hudson, Diane Hall, Dianna D Wardlow Dotter, Dolores E Price, Dylan R Jock, Edward D Harris, Emily Camire, Eric T Huebler, Erma Zaimova, Ernest Serna, III, Gail L Katz, Gene D Arcy, Ginger M Sykes, Gloria A Milster, Hanna L Potter, Helen B Ricalde, Ismael Olvera, IV, James D Planchon, James R Montero, Janet Pulver, Jennifer A Kemp, Jennifer M Pouget, Jessie E Morris, Judith A Jankowski, Judy Ellen Ciaraldi, Julian C Hanson, Karen J Bak, Kathleen B Swat, Kelly D Moore, Kelvin Cheung, L'oreal F Walker, Laureen F Kononen, Lauren E Swantko, Laurissa S Flowers, Lesley Maep Lutao, Lillie M Young, Linda S Mattingly, Lisa P Oakes, Marc A Jackson, Jr, Marion W Nadeau, Marla A Cassidy, Mary T Carden, Matthew J Gretkierewicz, Michael A Blaine, Michael E Maselli, Michele L Forster, PhD, Nathan R Moon, Neali H Lucas, Peter Kessler, PhD, Randy V Bong, Raymond W Brullo, Rebecca T Davis, Reginald Walker, Richard L Bartlett, Ricki A Chase, Ronda R Loyd Jones, Scott T Ballard, Secrist, Shelley H Beausoleil, Sherri J Jackson, Srinivas R Chennamaneni, PhD, Srinivas Rao Chennamaneni, PhD, State Agency, Stephen T Hansen, Tania Y Hall, Teena H Aiken, Theressa B Smith, Tracy J Washington, Travis S Bradley, Trushani T Desai, Tyra L Vanleer, Verdell Nelson, Vicky L Cruz, Vien Q Le, Wayne W Grundstrom, William F Lagud, Jr, William J Foust, Yvonne C Wilkes

Emily B Camire's Documents

Publish Date Document Type Title
September, 2021 FDA 483 BioLab Sciences, Inc. - Form 483, 2021-09-03
January, 2023 FDA 483 Utah Cord Bank LLC - Form 483, 2023-01-06
July, 2023 FDA 483 MD Tox Laboratory - Form 483, 2023-07-20
April, 2022 FDA 483 Fisch LTD d.b.a Green Valley Fertility Partners - Form 483, 2022-04-13
July, 2019 EIR Henry Ford Hospital - EIR, 2019-07-19
May, 2023 FDA 483 St Luke's Regional Medical Center - Form 483, 2023-05-04
July, 2022 FDA 483 St. George Regional Hospital - Form 483, 2022-07-20
May, 2022 FDA 483 Intermountain Medical Center - Form 483, 2022-05-12
March, 2019 FDA 483 ARUP Laboratories Inc. - Form 483, 2019-03-14
August, 2021 FDA 483 CellSure, L3C - Form 483, 2021-08-02
January, 2020 FDA 483 Octapharma Plasma Inc - Form 483, 2020-01-16
March, 2022 FDA 483 BioLife Plasma Services LP - Form 483, 2022-03-25
July, 2019 FDA 483 Response Henry Ford Hospital - Form 483R, 2019-08-02
March, 2019 EIR ARUP Laboratories, Inc. - EIR, 2019-03-11
February, 2023 FDA 483 Origin Biologics LLC - Form 483, 2023-02-10
February, 2022 FDA 483 Reproductive Care Center - Form 483, 2022-02-11
March, 2023 FDA 483 American National Red Cross (The), Lewis and Clark Region - Form 483, 2023-03-31
September, 2019 EIR R & B Medical Group Inc. - EIR, 2019-09-25
January, 2023 FDA 483 FIOR Bioscience LLC - Form 483, 2023-01-06
July, 2021 FDA 483 Conceptions Fertility Center - Form 483, 2021-07-13
July, 2019 FDA 483 Henry Ford Hospital - Form 483, 2019-07-19
December, 2019 FDA 483 Active Medical - Form 483, 2019-12-12
September, 2019 FDA 483 R & B Medical Group Inc. - Form 483, 2019-09-25
August, 2021 FDA 483 Right Cell, LLC - Form 483, 2021-08-03
August, 2021 FDA 483 CellSure, L3C - Form 483, 2021-08-02
August, 2022 FDA 483 Cedars-Sinai Medical Center - Form 483, 2022-08-26
December, 2023 FDA 483 HealthTech Wound Care, Inc. - Form 483, 2023-12-22
October, 2023 FDA 483 Utah Valley Hospital - Form 483, 2023-10-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more